Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Bever

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Neurology. Clinical Practice|August 22, 2018
Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic reviewJodie K Haselkorn, Christina Hughes, Alexander Rae-Grant, et al.
Medical Care|September 14, 2019
Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to ApplicationAmy M Kilbourne, Melissa Z Braganza, Nicholas W Bowersox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2013
Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targetsVamshi K Nimmagadda, Christopher T Bever, Narasimha R Vattikunta, et al.
Neurology|November 25, 2015
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyJodie K Haselkorn, Christina Hughes, Alex Rae-Grant, et al.
Journal of Neuroinflammation|November 20, 2015
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitisTapas K Makar, Volodymyr Gerzanich, Vamshi K C Nimmagadda, et al.
Autoimmune Diseases|May 2, 2012
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation StudyVijayshree Yadav, Dennis N Bourdette, James D Bowen, et al.
Journal of Neuroimmunology|May 13, 2008
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitisTapas K Makar, David Trisler, Christopher T Bever, et al.
Journal of Neuroinflammation|September 4, 2017
Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitisVolodymyr Gerzanich, Tapas K Makar, Poornachander Reddy Guda, et al.
Stroke|July 16, 2011
An economic analysis of robot-assisted therapy for long-term upper-limb impairment after strokeTodd H Wagner, Albert C Lo, Peter Peduzzi, et al.
Neurorehabilitation and Neural Repair|June 23, 2009
Multicenter randomized trial of robot-assisted rehabilitation for chronic stroke: methods and entry characteristics for VA ROBOTICSAlbert C Lo, Peter Guarino, Hermano I Krebs, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Neurology. Clinical Practice|August 22, 2018
Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic reviewJodie K Haselkorn, Christina Hughes, Alexander Rae-Grant, et al.
Medical Care|September 14, 2019
Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to ApplicationAmy M Kilbourne, Melissa Z Braganza, Nicholas W Bowersox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2013
Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targetsVamshi K Nimmagadda, Christopher T Bever, Narasimha R Vattikunta, et al.
Neurology|November 25, 2015
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyJodie K Haselkorn, Christina Hughes, Alex Rae-Grant, et al.
Journal of Neuroinflammation|November 20, 2015
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitisTapas K Makar, Volodymyr Gerzanich, Vamshi K C Nimmagadda, et al.
Autoimmune Diseases|May 2, 2012
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation StudyVijayshree Yadav, Dennis N Bourdette, James D Bowen, et al.
Journal of Neuroimmunology|May 13, 2008
Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitisTapas K Makar, David Trisler, Christopher T Bever, et al.
Journal of Neuroinflammation|September 4, 2017
Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitisVolodymyr Gerzanich, Tapas K Makar, Poornachander Reddy Guda, et al.
Stroke|July 16, 2011
An economic analysis of robot-assisted therapy for long-term upper-limb impairment after strokeTodd H Wagner, Albert C Lo, Peter Peduzzi, et al.
Neurorehabilitation and Neural Repair|June 23, 2009
Multicenter randomized trial of robot-assisted rehabilitation for chronic stroke: methods and entry characteristics for VA ROBOTICSAlbert C Lo, Peter Guarino, Hermano I Krebs, et al.
Pageof 6